Vancouver, British Columbia--(Newsfile Corp. - July 9, 2025) - Victory Square Technologies Inc. (CSE: VST) (OTC Pink: VSQTF) ("Victory Square" or the "Company"), a venture builder that provides public investors with access to early-stage technology companies, today announced its financial results for the three months ended March 31, 2025, and shared an update on its key business focus areas for the remainder of the year.Q1 2025 Financial Highlights Adjusted Revenue: $6.528MGAAP Revenue: $4.540MCost of Good ...

Expands access to precision-based care through at-home DNA testing and personalized health plansVANCOUVER, British Columbia and LAS VEGAS, May 27, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”) (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a fast-growing digital health platform delivering compliant mobile and telehealth services across all 50 U.S. states, is pleased to announce the launch of a new direct-to-consumer genetic testing and personalized wellness solution via its VS ...

Core Insights - Hydreight Technologies Inc. has reported significant growth in its financial performance for the fiscal year 2024, achieving record revenues and positive Adjusted EBITDA, while focusing on scaling its VSDHOne platform for 2025 [2][6][9]. Financial Performance - The company achieved record topline revenue of CAD 22.32 million in 2024, representing a 31% increase from 2023 [6][17]. - GAAP revenue for 2024 was CAD 16.04 million, up 39% from CAD 11.51 million in 2023 [6][9]. - Adjusted EBITDA for 2024 was CAD 490,000, a turnaround from a loss of CAD 1.38 million in 2023 [6][17]. - The gross margin for 2024 was CAD 5.75 million, an increase of 8% from the previous year [6][17]. - The fourth quarter of 2024 saw revenues of CAD 4.04 million, a 20% increase compared to the same quarter in 2023 [7][9]. Strategic Focus for 2025 - The company plans to expand franchise white-label partnerships to enhance its market presence [13]. - There is a focus on increasing pharmacy margins through supply chain optimization and strategic pricing [14]. - New wellness categories will be launched, including NAD+, testosterone replacement therapy, and peptide therapies [14]. - The onboarding of high-growth D2C healthcare companies on the VSDHOne platform will be accelerated [15]. - The company aims to attract and support more licensed nurses to enhance its provider network [15]. - Strategic tuck-in acquisitions of complementary D2C health brands are being pursued to improve product mix and margins [15]. Recognition and Milestones - Hydreight was ranked 9 on Deloitte's 2024 Technology Fast 50 list and 56 on the Technology Fast 500 list for North America [6][9]. - The company completed its first post-IPO financing, raising CAD 5.4 million in February 2025 to support its growth initiatives [6][9]. Operational Highlights - The company operates a network of over 3,000 nurses and 200+ physicians across all 50 states, facilitating a scalable telehealth and at-home care model [11][12]. - Hydreight's VSDHOne platform supports over 400 Direct to Consumer license holders, enabling rapid entry into the online healthcare space [11][21].